Combination therapies in psoriasis

Creative Commons License

Koc E., BÜLBÜL BAŞKAN E.

TURKDERM-TURKISH ARCHIVES OF DERMATOLOGY AND VENEROLOGY, cilt.56, ss.77-79, 2022 (ESCI) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 56
  • Basım Tarihi: 2022
  • Doi Numarası: 10.4274/turkderm.galenos.2022.77675
  • Dergi Adı: TURKDERM-TURKISH ARCHIVES OF DERMATOLOGY AND VENEROLOGY
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.77-79
  • Anahtar Kelimeler: Psoriasis, combination therapies, UVB, biologics, ETANERCEPT, PHOTOTHERAPY, MANAGEMENT, MODERATE
  • Bursa Uludağ Üniversitesi Adresli: Evet

Özet

Topical corticosteroids and vitamin D analogs can be combined with other topical, systemic, and biological agents. The effect of methotrexate can be enhanced with ultraviolet B (UVB) or psoralen ultraviolet A (PUVA). When a biological agent remains insufficient, the first agent to be added to the treatment is methotrexate. The use of acitretin in combination with phototherapy (both UVB and PUVA) has a synergistic effect. A UVB therapy may be combined with topical tar and anthralin as well as with etanercept and adalimumab, which are anti-tumor necrosis factor-alpha therapies.